|
⚲
|
| Keyboard |
| Jane Henderson | |
|---|---|
| Firm | |
| Address | c/o Adagio Therapeutics, Inc 303 Wyman Street, Suite 300 Waltham, MA 02451 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Adagio Therapeutics Inc | 021-397809 | Executive Officer | 335.5 M of 335.5 M |
||
| Turnstone Biologics Corp | 021-330976 | Executive Officer | 42.1 M of 42.1 M |
||
| Ophthotech Corp | 021-324993 | Director | 11.4 M of 11.7 M |
||
| Eleven Biotherapeutics Inc | 021-309400 | Director | 1.0 M of 1.0 M |
||
| Eleven Biotherapeutics Inc | 021-271427 | Director | 13.5 M of 13.5 M |
||
| Eleven Biotherapeutics Inc | 021-229571 | Director | 20.0 M of 20.0 M |
||
| Virginia Community Capital Inc | 021-228720 | Executive Officer | 11.5 M of 20.0 M |
||
| Kolltan Pharmaceuticals Inc | 021-213905 | Executive Officer | 60.0 M of 60.0 M |
||
| Virginia Community Capital Inc | 021-206712 | Executive Officer | 0.3 M of 15.0 M |
||
| Axerion Therapeutics Inc | 021-140586 | Executive Officer | 0.8 M of 0.8 M |
||